Showing results (451-460 of 577) with videos related to
Sort By:
Pageof 58
Biotechnology and Applied Biochemistry|April 28, 2022
Engineering processive cellulase of Clostridium thermocellum to divulge the role of the carbohydrate-binding moduleSajjad Ahmad, Muhammad Sajjad, Hisham N Altayb, et al.Molecules (Basel, Switzerland)|January 11, 2022
Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A ReviewMadhuchandra Kenchegowda, Mohamed Rahamathulla, Umme Hani, et al.Antioxidants (Basel, Switzerland)|May 28, 2022
Bioactive Phytochemicals of <i>Citrus reticulata</i> Seeds-An Example of Waste Product Rich in Healthy Skin Promoting AgentsTarfah Al-Warhi, Abeer H Elmaidomy, Samy Selim, et al.RSC Advances|April 10, 2023
Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigationSunil Kumar, Amritha Manoharan, Jayalakshmi J, et al.Molecules (Basel, Switzerland)|June 24, 2022
Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B InhibitorsMehmet Abdullah Alagöz, Jong Min Oh, Yaren Nur Zenni, et al.Phytochemistry|July 19, 2014
Asphodosides A-E, anti-MRSA metabolites from Asphodelus microcarpusMohammed M Ghoneim, Khaled M Elokely, Atef A El-Hela, et al.Molecules (Basel, Switzerland)|July 2, 2021
Targeting 3CLpro and SARS-CoV-2 RdRp by <i>Amphimedon</i> sp. Metabolites: A Computational StudyNourhan Hisham Shady, Alaa M Hayallah, Mamdouh F A Mohamed, et al.Nutrients|October 23, 2021
Pathobiological Relationship of Excessive Dietary Intake of Choline/L-Carnitine: A TMAO Precursor-Associated Aggravation in Heart Failure in Sarcopenic PatientsMay Nasser Bin-Jumah, Sadaf Jamal Gilani, Salman Hosawi, et al.Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Targeting Some Key Metalloproteinases by Nano-Naringenin and <i>Amphora coffeaeformis</i> as a Novel Strategy for Treatment of Osteoarthritis in RatsNema S Shaban, Abeer M Radi, Mohamed A Abdelgawad, et al.RSC Advances|March 27, 2023
Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigationSunil Kumar, Amritha Manoharan, Jayalakshmi J, et al.Pageof 58